Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · IEX Real-Time Price · USD
1.340
-0.020 (-1.47%)
At close: May 6, 2024, 4:00 PM
1.320
-0.020 (-1.49%)
Pre-market: May 7, 2024, 8:30 AM EDT
Akari Therapeutics, Analyst Ratings
Total Analysts
n/a
Consensus Rating
n/a
Price Target
n/a
Upside
n/a
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +2,138.81% | Dec 5, 2022 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $80 | Strong Buy | Initiates | $80 | +5,870.15% | Nov 1, 2022 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Mar 29, 2018 |
| B. Riley Securities | B. Riley Securities | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Feb 8, 2018 |
| William Blair | William Blair | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Sep 22, 2017 |
| Chardan Capital | Chardan Capital | Strong Sell → Hold Upgrades n/a | Strong Sell → Hold | Upgrades | n/a | n/a | May 31, 2017 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | May 12, 2017 |
| Chardan Capital | Chardan Capital | Strong Sell Reiterates n/a | Strong Sell | Reiterates | n/a | n/a | Apr 17, 2017 |